Ikena Oncology, Inc.IKNANASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank71
3Y CAGR+8.8%
5Y CAGR+59.9%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+8.8%/yr
vs +193.1%/yr prior
5Y CAGR
+59.9%/yr
Recent deceleration
Acceleration
-184.3pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
10.5x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$2.75M-49.7%
2024$5.47M-22.8%
2023$7.09M+231.4%
2022$2.14M+9200.0%
2021$23000.00-91.3%
2020$263000.00-84.3%
2019$1.68M+5675.9%
2018$29000.00-